Lespedeza Extract Skin Radiance Patent
Summary
European Patent Office published patent application EP3681467A2 for Clariant International Ltd covering the use of Lespedeza plant extract as an active ingredient in cosmetic compositions for increasing skin radiance. The patent application was published March 25, 2026, designating multiple European states.
What changed
The EPO published patent application EP3681467A2 for Clariant International Ltd on March 25, 2026, covering the use of Lespedeza plant extract as an active ingredient in compositions for increasing skin radiance. Inventors include YEOM Mi Ji, JUNG Eun Sun, PARK Deok Hoon, FRECHET Mathilde, and CHAJRA Hanane. The patent designates all EU member states plus Switzerland, Norway, Turkey, and other European countries.\n\nManufacturers and pharmaceutical companies in the cosmetics and skincare sectors should review the patent claims to assess potential impact on product development and freedom to operate. This is a routine patent publication creating no immediate compliance obligations. R&D teams may want to evaluate whether this intellectual property affects existing or planned formulations.
Source document (simplified)
USE OF AN EXTRACT FROM LESPEDEZA PLANT AS ACTIVE INGREDIENT IN A COMPOSITION FOR INCREASING RADIANCE OF THE SKIN
Publication EP3681467A2 Kind: A2 Mar 25, 2026
Applicants
Clariant International Ltd
Inventors
YEOM, Mi Ji, JUNG, Eun Sun, PARK, Deok Hoon, FRECHET, Mathilde, CHAJRA, Hanane
IPC Classifications
A61K 8/9789 20170101AFI20200123BHEP A61K 36/185 20060101ALI20200123BHEP A61Q 19/08 20060101ALI20200123BHEP A61Q 19/00 20060101ALI20200123BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.